Pharma & Biotech Market Research

KOL mapping that shows how experts will read your data.

Know which KOLs in pharma shape opinion in your therapy area, how they read the emerging data, and what they need answered before they change practice.

  • Research plan in 48 hours
  • US, UK and EU4 experts
  • KOL and practicing physician interviews
The outcome

Decide with evidence, not instinct.

A conference attendee raising a hand to ask the speaker a question
Evidence plans built without expert input answer questions the field stopped asking, and miss the ones it is asking now.
01

Know where expert opinion stands

See where experts agree, where they split and what would change their minds.

02

Close the evidence gaps that matter

Point evidence generation at the questions experts say are still open.

03

Lead with the message experts need

Medical communication focuses on the points experts find unclear or unconvincing.

What you receive

Kol mapping, in plain terms.

KOL mapping is the work of identifying the key opinion leaders (KOLs) in a therapy area and understanding where they stand on the science, the unmet need and the emerging data. Nextyn runs moderated interviews with KOLs and practicing physicians and maps where they agree, where they split and which scientific questions they still consider open.

A senior doctor raising a finger to make a point on a video call
You receive
  • A map of the experts who shape opinion
  • Expert views summarized by scientific topic
  • Evidence gaps and communication priorities, ranked
Questions it settles

The calls you can make with confidence.

  • What you will knowHow new data is being received by KOLs and practicing physicians, and which doubts remain.

    A senior physician reading case records in a hospital hallway
  • What you will knowThe questions experts want answered before they change practice, ranked by how widely they are raised.

    Two scientists discussing formulas written on a laboratory whiteboard
  • What you will knowThe topics that need clearer evidence or explanation, and the order to address them in.

    A doctor pointing at spine X-rays while explaining them to a man in a suit
A senior physician reading case records in a hospital hallwayTwo scientists discussing formulas written on a laboratory whiteboardA doctor pointing at spine X-rays while explaining them to a man in a suit
Case studies

Pharma & Biotech Market Research at work.

Masked clinicians discussing papers around a table, in black and white

Understanding how Phase III data could reshape clinical practice

What it settledIn-depth interviews with KOLs and practicing oncologists assessed the perceived differentiation of upcoming Phase III data, likely shifts in treatment algorithms and the scientific questions that remained unresolved, informing medical communications priorities.

Read the case study
Clinicians in gowns and masks reviewing papers around a meeting table
Two scientists smiling at results on a laboratory computer
Two clinicians in white coats reviewing results together

See all case studies

Start here

Which decision is waiting on better evidence?

Send us your question. We come back with a plan and a price. Nothing starts until you approve it.

  1. 01
    Tell us your question

    What you need to know, which markets, and by when.

  2. 02
    We send a plan

    Who we will speak to, how, and what it costs. Inside 48 hours.

  3. 03
    You approve it

    Nothing is commissioned until you say yes.

  4. 04
    We run it, and read it back

    Every interview read together: where they agree, where they conflict, and what is still open.

Get a research plan

How can we help you?

One research lead reads your brief and stays with it. We come back with an evidence plan before anything is commissioned.

We use these details to route your brief. No newsletter, no list.

Questions

KOL doctors meaning answered in plain terms.

Your privacy choices

We measure how this site is used and which campaigns bring people here. You can opt out at any time, which also stops any sale or sharing of your personal information for advertising.